down arrow

Avicanna, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05368K1003
  • TSE: AVCN
CAD
0.10
0.00 (0.00%)

Sep 22

TSE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Microbix Biosystems, Inc.
Rapid Dose Therapeutics Corp.
Ceapro, Inc.
Avicanna, Inc.
Cardiol Therapeutics, Inc.
BriaCell Therapeutics Corp.
Sernova Corp.
FSD Pharma, Inc.
Medicenna Therapeutics Corp.
Oncolytics Biotech, Inc.
Cognetivity Neurosciences Ltd.

Why is Avicanna, Inc. ?

1
The company has declared Negative results for the last 3 consecutive quarters
  • NET PROFIT(HY) At CAD -1.67 MM has Grown at -657.16%
  • DEBT-EQUITY RATIO (HY) Highest at -9.61 %
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -53.57%, its profits have fallen by -9.6%
3
Below par performance in long term as well as near term
  • Along with generating -53.57% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Avicanna, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Avicanna, Inc.
-58.82%
-0.71
62.78%
S&P/TSX 60
20.36%
2.51
12.02%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
75.08%
EBIT Growth (5y)
12.94%
EBIT to Interest (avg)
-6.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
11.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.06
EV to EBIT
-4.71
EV to EBITDA
-6.04
EV to Capital Employed
4.39
EV to Sales
0.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-93.12%
ROE (Latest)
-82.55%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(HY)

Higher at CAD -1.81 MM

ROCE(HY)

Highest at -108.06%

RAW MATERIAL COST(Y)

Fallen by -12.11% (YoY

-23What is not working for the Company
NET PROFIT(HY)

At CAD -1.81 MM has Grown at -173.25%

OPERATING CASH FLOW(Y)

Lowest at CAD -3.15 MM

INTEREST(HY)

At CAD 0.04 MM has Grown at 23.52%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.73 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 7.38 times

NET SALES(Q)

Lowest at CAD 5.64 MM

PRE-TAX PROFIT(Q)

Lowest at CAD -1.34 MM

Here's what is working for Avicanna, Inc.

Net Profit
Higher at CAD -1.81 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Raw Material Cost
Fallen by -12.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Avicanna, Inc.

Net Profit
At CAD -1.81 MM has Grown at -173.25%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CAD MM)

Pre-Tax Profit
At CAD -1.34 MM has Fallen at -67.51%
over average net sales of the previous four periods of CAD -0.8 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Operating Cash Flow
Lowest at CAD -3.15 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Interest
At CAD 0.04 MM has Grown at 23.52%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Net Sales
Lowest at CAD 5.64 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CAD MM)

Net Sales
At CAD 5.64 MM has Fallen at -12.72%
over average net sales of the previous four periods of CAD 6.46 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CAD MM)

Pre-Tax Profit
Lowest at CAD -1.34 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CAD MM)

Inventory Turnover Ratio
Lowest at 2.73 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 7.38 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading